Related Experiment Videos
Nonrandom chromosome abnormalities in angioimmunoblastic lymphadenopathy.
Blood
|October 1, 1982
Summary
Angioimmunoblastic lymphadenopathy (AILD) exhibits chromosome abnormalities in lymph nodes, suggesting a malignant nature. These findings indicate AILD may require aggressive chemotherapy despite its previously benign classification.
Area of Science:
- Oncology
- Genetics
- Pathology
Background:
- Angioimmunoblastic lymphadenopathy (AILD) is a complex lymphoid disorder.
- Clinical manifestations include lymphadenopathy, fever, weight loss, and rash.
- Immunoglobulin polyclonal elevation is common in AILD patients.
Observation:
- Cytogenetic and pathologic studies were conducted on six AILD patients.
- Lymph node biopsies revealed chromosome abnormalities in all five patients studied.
- Bone marrow biopsies showed no chromosome abnormalities in any patient.
Findings:
- Clonal chromosome abnormalities were detected in two patients' lymph nodes.
- An extra chromosome 3 was observed in four patients, clonal in two.
- Mosaicism of abnormal karyotypes suggests potential for clone selection and predominance.
Implications:
- The presence of clonal chromosome abnormalities suggests AILD may be a malignant disease.
- This contrasts with the historical view of AILD as a benign proliferative process.
- Findings support the need for aggressive chemotherapy in managing AILD.